Ardena is pleased to announce that a Commercial Agency Agreement for South Korea has been signed with the company Keyfronbio Co., Ltd.

Keyfronbio was established in May 2011 as a subsidiary of Biotoxtech Co., Ltd., the largest private non-clinical testing agency in Korea that has accumulated a long track record in the non-clinical and clinical fields of pharmaceuticals and is the first approved private CRO from US FDA GLP inspection.

Read the full press-release here.